Ann & Robert H Lurie Children's Hospital of Chicago
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Ann & Robert H Lurie Children's Hospital of Chicago sits in the top decile of US sponsors by registered trial count (#185 of 15,742 sponsors by registered trial count).
Ann & Robert H Lurie Children's Hospital of Chicago: 159 sponsored US clinical trials, 31 recruiting.
Ann & Robert H Lurie Children's Hospital of Chicago sponsors 159 registered US clinical trials on ClinicalTrials.gov, 31 of them currently recruiting, and 103 completed. 5 of these trials are in Phase 3-4 (later-stage) and 29 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Eosinophilic Esophagitis, with 6 trials.
Top-decile sponsor footprint
Ann & Robert H Lurie Children's Hospital of Chicago ranks in the top decile of sponsors by registered trial count (#185 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
103 of 112 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
159 total, page 3 of 4
A Comparison of the Laryngeal Mask Airway (LMA) Supreme and I-gel in Children
NCT01633073
HIV Prevention Intervention for Young Transgender Women
NCT01575938
MicroRNAs in Patients With Neurofibromatosis Type 1
NCT01595139
Ambu Aura-i and Air-Q Intubating Laryngeal Airways as a Conduit for Tracheal Intubation in Children
NCT01535742
Longitudinal Changes in Exercise Capacity in Children and Young Adults With Sickle Cell Anemia
NCT01558076
Longitudinal Study of Biomarkers
NCT01595126
A Comparison of the Laryngeal Mask Airway (LMA) Proseal and LMA Supreme in Children
NCT01449656
Resilience Promotion in Teens With Type 1 Diabetes: Preventing Negative Outcomes
NCT01490619
Acupuncture for the Treatment of Cancer Related Fatigue
NCT01572168
A Comparison of the LMA Unique and LMA Supreme in Children
NCT01409785
Neuromuscular Training to Reduce Sports Injuries Among Children and Adolescents
NCT01406054
Posterior Fossa Mutism on Quality of Life
NCT02048176
Blood and Cerebrospinal Fluid for Pediatric Brain Tumor Research
NCT01556178
LMA Unique TM & the Self Pressurized Air-Q TM Intubating Laryngeal Airway in Children
NCT01385761
Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases
NCT01586104
Prevention of Hypergranulation Tissue After Gastrostomy Tube Placement
NCT01501539
The Laryngeal Mask Airway (LMA) Unique and the Air-Q Intubating Laryngeal Airway (ILA) in Pediatric Patients
NCT01314248
Text Messaging Intervention to Improve ART Adherence Among HIV-positive Youth
NCT01354210
Perception, Awareness, and Acceptance of Human Papillomavirus Disease and Vaccine Among Parents of Boys Aged 9 to 18 Years
NCT01197079
Transversus Abdominis Plane Blocks for Infants and Children for Postoperative Pain Control
NCT01559740
Single Dose Pharmacokinetics and Pharmacodynamics of Bupivacaine Following Transversus Abdominis Plane (TAP) Block in Neonates
NCT01557985
Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma
NCT01088035
Circulating microRNAs as Disease Markers in Pediatric Cancers
NCT01541800
Randomized Controlled Trial of Antibiotics in the Management of Children With Community-Acquired Abscess
NCT01498744
Impact of Implementing an Infant Driven Feeding Program on Oral Feeding and Growth Outcomes of Medically Fragile Infants in the Neonatal ICU (NICU)
NCT01666457
Exercise Capacity in Pediatric Sickle Cell Anemia
NCT01527799
A Distraction Protocol for Peripheral Intravenous (IV) Placement in the Pediatric Emergency Department
NCT00924417
Postoperative Pain Control in Children Undergoing Laparoscopic Appendectomy: Peripheral Nerve Block Versus Local Anesthetic
NCT01662401
A Prospective Cohort Pilot Study of the Clinical and Molecular Epidemiology of Staphylococcus Aureus in Pregnant Women at the Time of Group B Streptococcal Screening in a Large Urban Medical Center in Chicago, IL USA
NCT00532324
Development and Validation of a Symptom Scale for Children With Chronic Graft-versus-Host Disease
NCT00632658
Evaluation of a Resident Curriculum in Firearm Injury Prevention
NCT01027104
Trial of Laparoscopic Compared to Open Inguinal Hernia Repair in Children Younger Than 3 Years
NCT00716768
HIV Prevention Among Vulnerable Male Youth
NCT01771237
Markers of Inflammation in Hematopoietic Stem Cell Transplant
NCT00579397
Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
NCT00619879
Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) Adolescent Bariatrics: Assessing Health Benefits and Risk
NCT00474318
Effect of Neuromuscular Warm-up on Injuries in Female Athletes
NCT01092286
Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary Hypertension
NCT00350844
Stamp-in-Safety Playground Safety Project
NCT00982917
Great Auricular Nerve Block for Children Undergoing Tympanomastoid Surgery
NCT01638052
The Impact of Implementing NIDCAP on Preterm Infants in the NICU
NCT00179933
Evaluation of Pulse Oximetry Sensors in Neonates
NCT00179972
Reduced Intensity Transplant Using Extracorporeal Photopheresis
NCT00179790
Measurements of Resting Energy Expenditure in Patients With or at Risk of Developing Graft Versus Host Disease
NCT00600314
The Impact of Implementing NIDCAP on the Developmental Sensitivity of Nurses Caring for Preterm Infants
NCT00179985
Does the Use of a Moisture Chamber Decrease the Incidence of Corneal Abrasions in Critically Ill Pediatric Patients?
NCT00129077
Pentostatin for High Risk and Refractory Chronic Graft Versus Host Disease in Children
NCT00144430
Extracorporeal Photopheresis for Acute Graft Versus Host Disease
NCT00179855
Home Safety Intervention Using a Safe Home Model
NCT00824486
HLA Matching - Unrelated Umbilical Cord Blood Transplantation
NCT00179946
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 13 |
| Phase 2 | 16 |
| Phase 3 | 2 |
| Phase 4 | 3 |
What is open in the Ann & Robert H Lurie Children's Hospital of Chicago pipeline
31 recruiting of 159 indexed (19% open); 103 completed (65%).
Phase mix: 5 late (III/IV) vs 29 early (I/II) (early-phase heavy).
Top condition: Eosinophilic Esophagitis (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Ann & Robert H Lurie Children's Hospital of Chicago: open-pipeline peers nationwide
Peers matched on 159 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
Ann & Robert H Lurie Children's Hospital of Chicago sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 159 trials (± recruiting share)
- Galderma R&D · 158 trials · 4% recruiting
- Pfizer's Upjohn has merged with Mylan to form Viatris · 158 trials · 0% recruiting
- University of South Carolina · 157 trials · 19% recruiting
- Alexion Pharmaceuticals · 162 trials · 10% recruiting
Sponsors near 19% open enrollment (± trial volume)
- Scripps Translational Science Institute · 20% recruiting · 41 trials
- UCB Biopharma SRL · 20% recruiting · 82 trials
- University of Texas Southwestern Medical Center · 19% recruiting · 837 trials
- The University of Texas Health Science Center, Houston · 20% recruiting · 732 trials
Related
What to do with this Ann & Robert H Lurie Children's Hospital of Chicago page
159 registered trials is a research-attention snapshot, not an endorsement of Ann & Robert H Lurie Children's Hospital of Chicago or any single study.
- 31 of Ann & Robert H Lurie Children's Hospital of Chicago's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Eosinophilic Esophagitis is the condition Ann & Robert H Lurie Children's Hospital of Chicago studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Eosinophilic Esophagitis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Ann & Robert H Lurie Children's Hospital of Chicago pipeline card: 159 registered trials from official public datasets.Report a data error.